These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26709653)

  • 1. Pharmacoepigenetics in gastrointestinal tumors: MGMT methylation and beyond.
    Fornaro L; Vivaldi C; Caparello C; Musettini G; Baldini E; Masi G; Falcone A
    Front Biosci (Elite Ed); 2016 Jan; 8(1):170-80. PubMed ID: 26709653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
    Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
    Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter Hypermethylation and Its Impact on Expression of MGMT Gene in the GIT Malignant Patients of Kashmiri Origin.
    Bhat AA; Wani HA; Ishaq S; Waza AA; Malik RA; Shabir I; Jeelani S; Kadla S; Qureshie W; Masood A; Majid S
    Cancer Invest; 2017 Feb; 35(2):116-121. PubMed ID: 28135856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O
    Watanabe H; Yamazaki Y; Fujishima F; Izumi K; Imamura M; Hijioka S; Toriyama K; Yatabe Y; Kudo A; Motoi F; Unno M; Sasano H
    BMC Cancer; 2020 Dec; 20(1):1195. PubMed ID: 33287738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation and expression profiles of MGMT gene in thymic epithelial tumors.
    Mokhtar M; Kondo K; Namura T; Ali AH; Fujita Y; Takai C; Takizawa H; Nakagawa Y; Toba H; Kajiura K; Yoshida M; Kawakami G; Sakiyama S; Tangoku A
    Lung Cancer; 2014 Feb; 83(2):279-87. PubMed ID: 24388682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).
    Cabrini G; Fabbri E; Lo Nigro C; Dechecchi MC; Gambari R
    Int J Oncol; 2015 Aug; 47(2):417-28. PubMed ID: 26035292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
    Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
    Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
    Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
    Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection.
    Sepulveda AR; Yao Y; Yan W; Park DI; Kim JJ; Gooding W; Abudayyeh S; Graham DY
    Gastroenterology; 2010 May; 138(5):1836-44. PubMed ID: 20044995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.
    Abouzeid HE; Kassem AM; Abdel Wahab AH; El-mezayen HA; Sharad H; Abdel Rahman S
    Tumour Biol; 2011 Oct; 32(5):845-52. PubMed ID: 21274674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.
    Raj N; Klimstra DS; Horvat N; Zhang L; Chou JF; Capanu M; Basturk O; Do RKG; Allen PJ; Reidy-Lagunes D
    Pancreas; 2017 Jul; 46(6):758-763. PubMed ID: 28609363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
    Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGMT-Methylation in Non-Neoplastic Diseases of the Central Nervous System.
    Teuber-Hanselmann S; Worm K; Macha N; Junker A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.
    Nagasaka T; Goel A; Notohara K; Takahata T; Sasamoto H; Uchida T; Nishida N; Tanaka N; Boland CR; Matsubara N
    Int J Cancer; 2008 Jun; 122(11):2429-36. PubMed ID: 18240147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is a rare event in soft tissue sarcoma.
    Jakob J; Hille M; Sauer C; Ströbel P; Wenz F; Hohenberger P
    Radiat Oncol; 2012 Oct; 7():180. PubMed ID: 23110891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningeal hemangiopericytomas: a clinicopathological study with emphasis on MGMT (O(6) -methylguanine-DNA methyltransferase) promoter methylation status.
    Kakkar A; Kumar A; Jha P; Goyal N; Mallick S; Sharma MC; Suri A; Singh M; Kale SS; Julka PK; Sarkar C; Suri V
    Neuropathology; 2014 Aug; 34(4):333-42. PubMed ID: 24521400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors.
    Bady P; Delorenzi M; Hegi ME
    J Mol Diagn; 2016 May; 18(3):350-361. PubMed ID: 26927331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline variation in O
    Belhadj S; Moutinho C; Mur P; Setien F; Llinàs-Arias P; Pérez-Salvia M; Pons T; Pineda M; Brunet J; Navarro M; Capellá G; Esteller M; Valle L
    Cancer Lett; 2019 Apr; 447():86-92. PubMed ID: 30677446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study.
    Campana D; Walter T; Pusceddu S; Gelsomino F; Graillot E; Prinzi N; Spallanzani A; Fiorentino M; Barritault M; Dall'Olio F; Brighi N; Biasco G
    Endocrine; 2018 Jun; 60(3):490-498. PubMed ID: 29150792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.